Kurosawa T, Sato M, Nakano H, Tohma M
Faculty of Pharmaceutical Sciences, Health Sciences University of Hokkaido, Japan.
Steroids. 1996 Jul;61(7):421-8. doi: 10.1016/0039-128x(96)00062-1.
Four stereoisomers of 3 alpha,7 alpha,12 alpha,24-tetrahydroxy-5 beta-cholestan-26-oic acids were synthesized as possible intermediates of the side-chain degradation step of bile acid biosynthesis. 3 alpha,7 alpha,12 alpha-Trihydroxy-5 beta-cholest-25-en-24-one prepared by thermolysis of beta-ketosulfoxide was reduced to the (24R)- and (24S)-allylic alcohols by reduction with sodium borohydride. Each isomeric alcohol was subjected to hydroboration and oxidation to give (25R)- and (25S)-3 alpha,7 alpha,12 alpha,24,26-pentahydroxy-5 beta-cholestanes. The separated four stereoisomers were converted into the corresponding 26-carboxylic acids. The stereoisomers of 3 alpha,7 alpha,24-trihydroxy-5 beta-cholestan-26-oic acids were synthesized in the same manner. To establish the stereochemistry of these carboxylic acids, the chemical transformation of methyl 3 alpha,7 alpha,12 alpha-trihydroxy- and 3 alpha,7 alpha-dihydroxy-5 beta-cholest-24-en-26-oates into the above stereoisomers and the reductive dehydroxylation of the 24-hydroxyl group into known 3 alpha,7 alpha,12 alpha,26-tetrahydroxy- and 3 alpha,7 alpha,26-trihydroxy-5 beta-cholestanes are described. The applications of spectroscopic methods (circular dichroism and 1H nuclear magnetic resonance) to elucidation of the stereochemistry are also discussed.
合成了3α,7α,12α,24 - 四羟基 - 5β - 胆甾烷 - 26 - 酸的四种立体异构体,作为胆汁酸生物合成侧链降解步骤的可能中间体。通过β - 酮亚砜的热解制备的3α,7α,12α - 三羟基 - 5β - 胆甾 - 25 - 烯 - 24 - 酮,用硼氢化钠还原得到(24R) - 和(24S) - 烯丙醇。每种异构体醇进行硼氢化和氧化反应,得到(25R) - 和(25S) - 3α,7α,12α,24,26 - 五羟基 - 5β - 胆甾烷。分离得到的四种立体异构体转化为相应的26 - 羧酸。3α,7α,24 - 三羟基 - 5β - 胆甾烷 - 26 - 酸的立体异构体以相同方式合成。为确定这些羧酸的立体化学,描述了3α,7α,12α - 三羟基 - 和3α,7α - 二羟基 - 5β - 胆甾 - 24 - 烯 - 26 - 酸甲酯向上述立体异构体的化学转化以及24 - 羟基还原脱羟基为已知的3α,7α,12α,26 - 四羟基 - 和3α,7α,26 - 三羟基 - 5β - 胆甾烷的过程。还讨论了光谱方法(圆二色性和1H核磁共振)在阐明立体化学中的应用。